A novel biomarker which may help determine which patients require a CT scan has been approved by the FDA.
Researchers have observed improvements in the cognitive function of mice after reversing the formation of beta-amyloid plaques.
New research suggests Huntington’s disease may provide protection from cancer.
Researchers from Queensland University of Technology have identified a drug that could reverse the damaging effects of heavy alcohol consumption on neurogenesis.
A collaborative study from researchers in Poland and Sweden has presented a novel combination of mechanisms that may lead to neuronal cell death in Alzheimer’s disease.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
Pharmaceutical policy announcements, promising drug trial data and more: check out our round-up of the biggest news from the neuroscience and neurology industry this week
From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
A long-term study suggests that traumatic brain injury can have long-term effects that increase the risk of developing dementia.
Balovaptan, a molecule being developed by Roche for autism spectrum disorder, has been given FDA approval in order to accelerate its development.